Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-057159

EVP, R&D & Chief Scientific Of sold 6,000 shares at $14.35 ($86,100)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Haqq Christopher EVP, R&D & Chief Scientific Of 2017-10-16 Sale −6,000 $14.35 $86,100 343,305 D: show line 1 in the form
Open-market sales · 6,000 sh · avg $14.35 · $86,100
Loading xslF345X03/doc4.xml…